Scott Waldman
Director, MD/PhD Program · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Credentials: · · · ·
History
PresentDepartment of Pharmacology & Experimental Therapeutics · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
- Present
Pharmacology Department · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Research
Guanylyl cyclases and signaling by cyclic GMP
Review · Pharmacological Reviews · 2000 · Last of 8 authors · 915 citations
Cyclic GMP synthesis and function
Review · Pharmacological Reviews · 1987 · First of 2 authors · 875 citations
Journal of Biological Chemistry · 1984 · First of 3 authors · 731 citations
- JL
22 papers
19 papers
16 papers · 2 as a resident
- DL
15 papers · 1 as a resident
15 papers
14 papers
- JP
11 papers
10 papers · 3 as a resident
Grants
- 1995–2030
Clinical Pharmacology Training Program
National Institute of General Medical Sciences · T32
Contact PI · $10.4M · Thomas Jefferson University
- 2025–2030
Clinical Pharmacology Training Program
National Institute of Child Health and Human Development · T32
PI · $408.6K · Thomas Jefferson University
- 2023–2028
Targeting Visceral Pain Through Intestinal Neuropod Cell GUCY2C Signaling
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.4M · Thomas Jefferson University
- 2023–2026
Neuroprotection by the GUCY2C Gut-Brain Axis in Parkinson's Disease
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $429K · Thomas Jefferson University
Clinical trials
- 2019–2026
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Principal investigator · Active not recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- 2013–2016
Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
Study director · Completed · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University